Key Insights

Highlights

Treatment Research

1 treatments under study, led by Phenylalanine Phe

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07220265Not ApplicableRecruitingPrimary

Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers

Showing all 1 trials

Research Network

Common Treatments

  • Phenylalanine Phe1

Active Sponsors

  • University of Missouri-Columbia1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Related Conditions

  • Healthy1

Activity Timeline